Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Chemical Communications (Cambridge, England)|February 9, 2013
The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imagingGraeme J Stasiuk, Nicholas J LongDalton Transactions (Cambridge, England : 2003)|November 4, 2009
Click chemistry with lanthanide complexes: a word of cautionGraeme J Stasiuk, Mark P LoweChemical Communications (Cambridge, England)|October 30, 2023
ATP-responsive Mn(II)-based <i>T</i><sub>1</sub> contrast agent for MRISellamuthu Anbu, Lawerence Kenning, Graeme J StasiukDalton Transactions (Cambridge, England : 2003)|February 12, 2016
Current advances in ligand design for inorganic positron emission tomography tracers <sup>68</sup>Ga, <sup>64</sup>Cu, <sup>89</sup>Zr and <sup>44</sup>ScThomas W Price, John Greenman, Graeme J StasiukCurrent Opinion in Pharmacology|August 14, 2012
Novel imaging chelates for drug discoveryGraeme J Stasiuk, Stephen Faulkner, Nicholas J LongDalton Transactions (Cambridge, England : 2003)|January 13, 2015
Towards understanding the design of dual-modal MR/fluorescent probes to sense zinc ionsCharlotte Rivas, Graeme J Stasiuk, Myra Sae-Heng, et al.Chemical Society Reviews|July 24, 2020
The use of yttrium in medical imaging and therapy: historical background and future perspectivesBen J Tickner, Graeme J Stasiuk, Simon B Duckett, et al.Theranostics|September 15, 2021
Smart magnetic resonance imaging-based theranostics for cancerBeatriz Brito, Thomas W Price, Juan Gallo, et al.Chemical Communications (Cambridge, England)|June 30, 2018
Selective radiolabelling with <sup>68</sup>Ga under mild conditions: a route towards a porphyrin PET/PDT theranostic agentSteven Y Yap, Thomas W Price, Huguette Savoie, et al.Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A ReviewPaul M D Gape, Michael K Schultz, Graeme J Stasiuk, et al.Pageof 5